Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2023

Conditions
Pancreatic CancerResectable Pancreatic Cancer
Interventions
DRUG

Pimonidazole

Patients will take a single dose of 0.5 g/m\^2 (approximately 13 mg/kg) of oral pimonidazole HCI 16 to 24 hours prior to surgery.

PROCEDURE

Surgical Resection

Patients will undergo Pancreaticoduodenectomy or Whipple procedure, which involves the resection of the pancreatic head, duodenum, gallbladder, and a portion of the stomach, 16 to 24 hours after consuming oral pimonidazole.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER